Alpharetta, GA (PRWEB) October 31, 2011
Imedex, LLC will present Hematology Highlights 2012: Expert Reviews of the Annual Hematology Meeting in New York, New York on January 14, 2012 and San Francisco, California on January 21, 2012. This continuing medical education (CME) opportunity has a target audience of hematologists, oncologists, and other health-care professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc.) involved or interested in the therapeutic management of patients with hematologic malignancies and benign hematologic conditions.
The New York City oncology CME event will be moderated by Dr. Morton Coleman, the director for the Center for Lymphoma and Myeloma at New York Presbyterian Hospital-Weill Cornell Medical Center and also the clinical professor of medicine at Weill Cornell Medical College. Dr. Coleman is recognized as a Top Doctor by New York Times and Weill Cornell has established a professorship in his name. The moderator for the San Francisco oncology CME event will be Dr. Rafael Fonseca, a world-leading myeloma researcher and Hematology/Oncology physician at the Mayo Clinic. Dr. Fonseca pioneers individualized therapies based on genetic markers for multiple myeloma research.
Join us for our Hematology Highlights 2012 interactive gastroenterology CME session where experts and attendees from the audience will exchange information through a state-of-the-art speaker-audience interaction system. As participants answer multiple-choice questions their selections are calculated and graphed in real-time, and projected on-screen for all to see. This visual system allows attendees from diverse disciplines to both recognize differing opinions and build consensus between the speakers and one another.
This oncology continuing medical education opportunity, will provide attendees the latest information and contribute to:
- An awareness of clinical advances in hematology and their potential to improve upon current practices
- Insight into malignant and benign hematologic conditions, and how these findings are being used on a genetic and molecular biological level to develop novel prognostic and therapeutic strategies
- Confidence in evaluating potential benefits and risks of novel therapies for malignant and benign hematologic conditions and how to navigate practical issues while incorporating these agents into patient care
- Frequency of plans to integrate practice-changing new data, or when appropriate, into treatment decisions for patients with malignant or benign hematologic conditions
For more information about this exciting oncology cme activity and to register for the Hematology Highlights 2012: Expert Reviews of the Annual Hematology Meeting on January 14, 2012 in New York City and January 21, 2012 in San Francisco.
Email us at registration(at)imedex(dot)com
Call us toll-free at 1 (855) 276 6855
Online at http://www.hematologyhighlights.com
Early registration for New York City ends November 14, 2011.
Early registration for San Francisco ends November 21, 2011
For event updates, connect with us! Find us on:
Facebook at http://www.facebook.com/Hematologyhighlights.
Key Terms: Hematology CME, Oncology CME, Gastroenterology CME, Physician CME, Physicians-in-Training CME, Pharmacy CME, Physicians’ Assistants CME, Oncology Nurse CE
About Imedex, LLC
Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality, scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.
Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, we believe that education is the best medicine.®
Release issued by Audience Generation, LLC
Audience Generation is a forward thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated marketing, advertising, and technology services and solutions that offer a new way to find, generate, and engage live, online, social and mobile audiences where they exist on demand.
Audience Generation is known for its creative strategy, actionable solutions and measurable approach to transforming the ways brands interact with their target audience where they exist in person, online, via social networks or on their mobile devices.
Audience Generation has produced winning traditional, online, e-commerce, social and mobile campaigns including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture backed start-up companies across a variety of industry verticals around the World.
To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand and grow your bottom line please call us at 512-708-4678 or email us at growyourbusiness(at)audiencegeneration(dot)com or visit us at: http://www.audiencegeneration.com.
# # #